ZURICH (Reuters) – Novartis has appointed AbbVie executive Patrick Horber to its executive committee, the Swiss pharmaceuticals maker said on Wednesday, after Chief Commercial Officer Marie-France Tschudin stepped down.
Horber, currently Senior Vice President and President, Immunology at AbbVie has been appointed as President, International, effective later this year.
Tschudin, President, Innovative Medicines International and Chief Commercial Officer, has decided to leave Novartis after seven years with the company and will step down from the executive committee, effective September 15.
(Reporting by John Revill; Editing by Miranda Murray)
